Details

Portfolio

Advancing Portfolio

Screening Program

Project Completed

RFP Year

2015
Awarded Amount

$79,200
Disease

Tuberculosis
Intervention

Drug
Development Stage

Hit Identification
Collaboration Partners

Sumitomo Dainippon Pharma Co., Ltd. , The Global Alliance for TB Drug Development